Multidimensional Family Therapy for Adolescent Cannabis Users - Cannabis Youth Treatment Series (Volume 5) - Services, U. S. Department of Health and
27,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
  • Broschiertes Buch

Multidimensional Family Therapy (MDFT)-Multidimensional family therapy is the multisystemic family-focused treatment described in this manual for experienced family therapists that includes 12 weeks of in-clinic and telephone sessions working with individual adolescents and their families. MDFT targets the psychosocial functioning of individual family members, the family members' relationships, and influential social systems outside the family.

Andere Kunden interessierten sich auch für
Produktbeschreibung
Multidimensional Family Therapy (MDFT)-Multidimensional family therapy is the multisystemic family-focused treatment described in this manual for experienced family therapists that includes 12 weeks of in-clinic and telephone sessions working with individual adolescents and their families. MDFT targets the psychosocial functioning of individual family members, the family members' relationships, and influential social systems outside the family.
Autorenporträt
TIP 63 Update--- To ensure that the content of this TIP is as up to date and as useful to readers as possible, SAMHSA, in January 2020, revised certain areas of all five parts. These changes will help provide readers with the latest information needed to understand medications for opioid use disorder. These changes included the following: . Updating statistics from SAMHSA, the Centers for Disease Control and Prevention, and other health authorities on opioid-related deaths, overdoses, accidents, and hospitalizations. . Updating the expanded list of other qualifying practitioners who are eligible to apply for a waiver to prescribe buprenorphine (i.e., clinical nurse specialists, certified registered nurse anesthetists, and certified nurse midwives). . Clarifying that buprenorphine is available in an extended-release injection formulation. . Adding information about the use of subdermal formulations of buprenorphine (i.e., Probuphine and Sublocade). . Adding information about possible clinical interactions between formulations of buprenorphine and naltrexone with various other medications and products. . Improving the language to make clear the importance of testing for HIV and hepatitis C. . Updating recommendations from the U.S. Preventive Services Task Force on performing drug screening for adults in primary care settings. . Removing or replacing broken hyperlinks to online resources.